News
Imara reports additional pre-clinical and Phase 1 data for lead compound, IMR-687, at the 6th Annual Sickle Cell Therapeutics Conference in New York.
The presentation will be available on the Investors section of the Imara website. About IMR-261 IMR-261 (formerly CXA-10) is an activator of nuclear factor erythroid 2–related factor 2, or Nrf2.
The 110 propellants listed in the Hornady Handbook of Cartridge Reloading Fifth Edition appear in order of burn rate, from fastest to slowest. IMR 7828 is 100th. AA 8700 is 107th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback